PHOENIXBIO: Notice regarding financial results of unlisted parent companies, etc.

JPXMay 15 14:30 · Announcements

PHOENIXBIO: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

JPXMay 15 14:30 · Announcements

PhoenixBio Sees FY Net Y201.00M

PhoenixBio Co. Ltd. also released the following forecasts: GROUP 1st Half To Year Ending Sep 2024 Mar 2025 Revenue Y972.00 mln Y2.12 bln Op

Dow JonesMay 15 14:30

PhoenixBio 9-Mos Net Y14.00M Vs Net Y393.00M

PhoenixBio Co. Ltd. (6190.TO) Japan Nine Months Ended December 31 GROUP 2023 2022 Revenue Y1.33 bln Y1.66 bln Operating Profit Y30.00 ml

Dow JonesFeb 14 14:33

PhoenixBio Sees FY Net Y24.00M

PhoenixBio Sees FY Net Y24.00M

Dow JonesNov 14, 2023 14:32

PhoenixBio 1Q Net Y42.00M Vs Net Y103.00M

PhoenixBio Co. Ltd. (6190.TO) Japan 1st Quarter Ended June 30 GROUP 2023 2022 Revenue Y439.00 mln Y445.00 mln Operating Profit Y7.00 mln

Dow JonesAug 14, 2023 14:30